Company / Gross Profit
Vericel Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$205.6M
FY2025
5-year range
$80.3M / $205.6M
FY2021-FY2025
Trend
+19.5%
vs FY2024
Sector context
#21 of 29
Health Care
What the data says
At $206M, Vericel's gross profit ranks #21 of 29 in the Health Care sector. Gross Profit has increased for 9 consecutive years, from $12M in FY2016 to $206M in FY2025.
Based on SEC 10-K filings.
$206M in FY2025 with a 5-year CAGR of +28.5%.
Improved from $136M to $206M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +34.6%
- 5-Year CAGR
- +28.5%
- 10-Year CAGR
- -
Sector benchmark
#21 of 29 in Health CareTop 72% of 29This company $205.6M Sector average $3.5B
▼
-94.1% below sector average
Key checks
Key Insights
- Vericel's gross profit has grown for 9 consecutive years.
- 5-year CAGR of +28.5%, indicating consistent growth.
- In FY2025, gross profit increased 19.5% year-over-year.
- Ranks #21 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $205.6M | +19.5% |
| FY2024 | $172.1M | +26.9% |
| FY2023 | $135.6M | +61.0% |
| FY2022 | $84.2M | +4.9% |
| FY2021 | $80.3M | +36.8% |
| FY2020 | $58.7M | +74.8% |
| FY2019 | $33.6M | +28.7% |
| FY2018 | $26.1M | +5.6% |
| FY2017 | $24.7M | +114.7% |
| FY2016 | $11.5M | +76586.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026